Delve Health

Delve Health Decentralized Clinical Trial Solution, bringing clinical trials to patient homes

Here's something that quietly derails wearable-enabled clinical trials: enrollment isn't adoption.A device on a patient'...
05/21/2026

Here's something that quietly derails wearable-enabled clinical trials: enrollment isn't adoption.

A device on a patient's wrist isn't the same as a device worn correctly, charged, and synced every day. And when patients drift, it doesn't show up in the enrollment numbers — it shows up later, in the endpoint data, as gaps you can't fix after the fact.

The technology is the easy part. Keeping patients using it correctly, week after week, is the real work — and it takes setup support, monitoring for non-wear, and follow-up the moment the data stops.

How does your team keep wearable data flowing once the novelty wears off?

More on how we approach this: https://www.delvehealth.com/wearable-compliance-clinical-trials.html

05/15/2026

Subject matter expertise is key when using AI tools like ChatGPT. If you understand the topic, you can identify errors. Power requires responsibility.
See full video here https://youtu.be/AFtsMb1_4VA

05/05/2026

It's not about the fancy tech; it's about empowering people. Think GPS for drivers—it guides, but doesn't replace skill. We can train good clinicians for new protocols, but not with scattered resources. Let's focus on enabling participation.

04/30/2026

Dropout rates and late trial starts cost the industry billions. The human element is key to engagement and retention, yet we often overlook what makes people comfortable. Standardized measurement in behavioral and survey science can turn subjective feedback into reliable data, proving ROI and serving patients better.

omething worth sharing if you work in clinical research:The industry has made serious progress on wearable technology in...
04/22/2026

omething worth sharing if you work in clinical research:
The industry has made serious progress on wearable technology in clinical trials. Devices are more capable than ever. Regulatory acceptance is growing — the FDA expanded its real-world evidence framework just last December.

But there's a gap that doesn't get talked about enough.

Collecting the data and using the data are two very different problems.

A wearable can generate thousands of data points per patient per day. If the analytics aren't protocol-aligned, if patients aren't supported through the full study duration, if sites don't have clean workflows around the device — that data doesn't do what you needed it to do.

The teams getting this right aren't just deploying better devices. They're building better ex*****on infrastructure around them.

That's the real differentiator in 2026.

04/21/2026

New full episode is live on Spotify.

Clinical trials have more technology, more tools, and more data than ever before.
So why are patient retention, trial compliance, and patient experience still such persistent problems?

In this episode, I sat down with Farah Ahmad, Co-Founder and CEO of PatientX and EVP of Business Development at Eversana, for a candid conversation about what the industry still gets wrong when it comes to the patient journey.

We talked about:
• patient retention in clinical trials
• patient engagement and patient voice
• trial compliance and operational gaps
• decentralized clinical trials and digital health
• clinical trial innovation and better trial design
• how sponsors, sites, and partners can work better together

One of the biggest takeaways for me: we keep trying to solve deeply human problems with disconnected systems, fragmented processes, and too little ownership around the actual participant experience.

If we want better data, better compliance, and better outcomes, we have to build trials that work better for the people inside them.
This conversation is for anyone working in clinical research, clinical operations, pharma, biotech, digital health, or patient-focused innovation.

Listen to the full episode on Spotify and let me know what you think the industry still misses most when it comes to retention.

Big news! 🏆 Delve Health has officially been named one of the Fastest-Growing Companies in the Midwest by ! 🚀From 2022 t...
04/06/2026

Big news! 🏆 Delve Health has officially been named one of the Fastest-Growing Companies in the Midwest by ! 🚀

From 2022 to 2025, our team has been on a mission to transform clinical trials and make healthcare more accessible through innovation. Being recognized on the list is a huge milestone for us, and it’s all thanks to our incredible team, partners, and clients.

We’re not just growing; we’re evolving the future of health-tech. Thank you for being part of our journey! 🥂✨

04/04/2026

What happens when a real human shows up for a clinical trial patient? 👇

James was dropping off. Missed diaries. Unsynced wearable. Week 3 of a vaccine study.

Our concierge called him. Stayed on the phone. Got everything sorted.

✅ Diary completion: 18% → 91%
✅ Wearable adherence: 24% → 88%
✅ Retention: 96%
✅ Dropouts after that call: zero

This is Video 3 of our series showing why human engagement isn’t a nice-to-have in clinical trials — it’s the whole game.

📌 Book a demo — link in bio.

—

04/01/2026

Had a great conversation with Denali Rose on the podcast about where clinical research is really headed — and what still has not changed enough.

A few themes stood out:
Clinical research still struggles with the same core challenges we were talking about years ago.

Poor communication.
Disconnected stakeholders.
Operational friction at the site level.

And too many solutions built in isolation instead of with the people who actually use them.

We also talked about:
why site sustainability matters more than ever
where AI may help in clinical trials — and where it is still overhyped
why interoperability still matters
why patient engagement and education remain deeply under-addressed
and why authenticity and transparency are still some of the most important things this industry can offer

One thing I appreciated most from this conversation was Denali’s perspective on sites: they do critical work, care deeply, and deserve better support, better autonomy, and better financial viability.

That is a conversation this industry needs to keep having.

If you work in clinical operations, site strategy, patient engagement, clinical trial technology, or digital health, this one is worth the listen.

🎙️ Watch / listen here: https://lnkd.in/gbumN-yR

What do you think is the biggest issue we still have not solved in clinical research?



Spotify: https://lnkd.in/gcREmuY5

04/01/2026

No one sees this part of a clinical trial.

A patient leaves the visit…
and everything starts to drift.

Confusion.
Missed ePRO entries.
Wearables not syncing.
Questions with no answers.

Not because they don’t care—
because there’s no support between visits.

So what happens?

Compliance doesn’t drop overnight.
It erodes.

Quietly.
Predictably.
Constantly.

➡️ This is where patient retention and data quality start to break.

Episode 1 of 3: What Happens Between Visits in Clinical Trials

Vaccine trials are global. Ex*****on has to be too.As conversations build around the World Vaccine Congress, one reality...
03/31/2026

Vaccine trials are global.
Ex*****on has to be too.

As conversations build around the World Vaccine Congress, one reality stands out:
Most vaccine studies are designed for diverse, global populations…
but executed with assumptions that don’t hold in the real world.

Connectivity isn’t guaranteed.
Engagement isn’t automatic.
Follow-up isn’t consistent.

At Delve Health, we focus on what actually makes global vaccine studies work:
Ex*****on across every environment—not just ideal ones.
• Offline-first eCOA/ePRO that captures data without internet
• Devices that store and sync when connectivity returns
• Multilingual patient engagement in 100+ languages
• Concierge support that actively follows up—not just sends reminders
• Real-time visibility into compliance, drift, and missing data

Because in vaccine trials:
If patients can’t stay connected,
your data won’t stay complete.

And global studies don’t fail because of science—
they fail when ex*****on doesn’t match reality.

We help sponsors and CROs run vaccine studies the way they actually happen:
Across countries.
Across connectivity levels.
Across real patient lives.

If you're following World Vaccine Congress, let’s rethink how global trials are executed.

Address

8100 Wayzata Boulevard
Golden Valley, MN
55426

Website

Alerts

Be the first to know and let us send you an email when Delve Health posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Delve Health:

Shortcuts

Share

Category